

Past Event
9:00 am - 5:00 pm EDT
1775 Massachusetts Ave., NW
Washington, DC
Three years ago, the U.S. Food and Drug Administration (FDA) launched the Sentinel Initiative, making significant progress in developing a system for conducting active surveillance of medical products. On September 26-27, the Engelberg Center hosted an event to reflect on the progress of the Initiative to date, and to consider its future direction and sustainability.
This event brought together a diverse set of stakeholders to reflect on the progress of the Initiative made to date, and consider its future direction to ensure sustainability of the system and reliability of results generated, including:
Matthew Fiedler
February 12, 2025
Amy Goldstein
February 11, 2025
Wendell Primus, Tara Watson, Jack A. Smalligan
February 11, 2025